We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.77%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
–
AUM
$34.5B
AUM Growth
+$3.25B
(+10%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
36.04%
Holding
1,621
New
350
Increased
531
Reduced
497
Closed
212
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$738M |
| 2 |
Apple
AAPL
|
+$684M |
| 3 |
Tesla
TSLA
|
+$552M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
| 5 |
Qualcomm
QCOM
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$579M |
| 2 |
Adobe
ADBE
|
+$370M |
| 3 |
AbbVie
ABBV
|
+$311M |
| 4 |
Uber
UBER
|
+$281M |
| 5 |
Pinduoduo
PDD
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.94% |
| 2 | Consumer Discretionary | 12.21% |
| 3 | Communication Services | 11.41% |
| 4 | Healthcare | 8.92% |
| 5 | Financials | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Jack Henry & Associates
JKHY
$11.1B
| $201K | ﹤0.01% |
1,201
-17,696
| -94% | -$2.86M |
|
1377
BridgeBio Pharma
BBIO
$16.5B
| $196K | ﹤0.01% |
11,755
+3,686
| +46% | +$156K |
|
1378
Western Union
WU
$2.21B
| $190K | ﹤0.01% |
10,671
-5,584
| -34% | -$103K |
|
1379
Nektar Therapeutics
NKTR
$2.58B
| $187K | ﹤0.01% |
+925
| New | +$201K |
|
1380
ADMA Biologics
ADMA
$2.22B
| $185K | ﹤0.01% |
131,444
+49,899
| +61% | +$65.6K |
|
1381
BioCryst Pharmaceuticals
BCRX
$2.4B
| $183K | ﹤0.01% |
13,236
-53,891
| -80% | -$713K |
|
|
NPKI
1382
NPK International
NPKI
$1.14B
| $183K | ﹤0.01% |
62,396
+20,675
| +50% | +$66.4K |
|
|
LCI
1383
DELISTED
Lannett Company, Inc.
LCI
| $183K | ﹤0.01% |
28,170
-34,700
| -55% | -$297K |
|
1384
Recursion Pharmaceuticals
RXRX
$1.73B
| $174K | ﹤0.01% |
+10,179
| New | +$192K |
|
1385
Zimmer Biomet
ZBH
$18.4B
| $157K | ﹤0.01% |
1,275
-166
| -12% | -$21.7K |
|
|
FARM
1386
DELISTED
Farmer Brothers
FARM
| $149K | ﹤0.01% |
19,975
-25,558
| -56% | -$188K |
|
|
ESTE
1387
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $146K | ﹤0.01% |
13,379
-32,890
| -71% | -$351K |
|
1388
Western New England Bancorp
WNEB
$275M
| $138K | ﹤0.01% |
+15,787
| New | +$143K |
|
1389
Airgain
AIRG
$72.4M
| $136K | ﹤0.01% |
12,786
-18,850
| -60% | -$203K |
|
|
ELVT
1390
DELISTED
Elevate Credit, Inc.
ELVT
| $128K | ﹤0.01% |
43,070
-144,298
| -77% | -$490K |
|
1391
Fortuna Silver Mines
FSM
$3.07B
| $125K | ﹤0.01% |
+31,948
| New | +$131K |
|
1392
Karyopharm Therapeutics
KPTI
$48M
| $125K | ﹤0.01% |
+1,291
| New | +$129K |
|
|
HALL
1393
DELISTED
Hallmark Financial Services, Inc.
HALL
| $115K | ﹤0.01% |
+2,643
| New | +$102K |
|
1394
Aldeyra Therapeutics
ALDX
$93.5M
| $106K | ﹤0.01% |
26,392
-42,827
| -62% | -$327K |
|
1395
Geospace Technologies
GEOS
$75.7M
| $99K | ﹤0.01% |
14,823
-7,632
| -34% | -$66.7K |
|
1396
Vipshop
VIPS
$7.53B
| $96K | ﹤0.01% |
11,429
+808
| +8% | +$8.45K |
|
1397
Ocular Therapeutix
OCUL
$2.02B
| $95K | ﹤0.01% |
13,694
-5,903
| -30% | -$45.8K |
|
|
SGMO
1398
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $94K | ﹤0.01% |
+12,476
| New | +$108K |
|
|
ZNGA
1399
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $92K | ﹤0.01% |
14,317
-609
| -4% | -$4.2K |
|
1400
AquaBounty Technologies
AQB
$6.02M
| $71K | ﹤0.01% |
+1,684
| New | +$108K |
|
Similar funds
Assenagon Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Assenagon Asset Management held 1,621 positions worth $34.5B, up 10% from $31.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Assenagon Asset Management deployed $1.75B of net new capital in Q4 2021, opening 350 new positions and adding to 531 existing holdings. Its largest new stake was Vale: 4,012,602 shares worth $56.3M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Amazon, an estimated $579M trimmed.
- Assenagon Asset Management's largest Q4 2021 buy was Vale: 4,012,602 shares worth $56.3M.
- Assenagon Asset Management added most to Microsoft in Q4 2021, an estimated $738M increase.
- Assenagon Asset Management's biggest Q4 2021 reduction was Amazon, cutting an estimated $579M.
- Assenagon Asset Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $82M.
- Assenagon Asset Management's ten largest holdings make up 36% of its $34.5B portfolio in Q4 2021.
- Assenagon Asset Management opened 350 new positions and closed 212 in Q4 2021.
- Assenagon Asset Management's portfolio value rose 10% quarter-over-quarter to $34.5B.
Based on Assenagon Asset Management's 13F filing for Q4 2021, filed 1 Feb 2022.